Moderna lifts lid on OpenAI artificial intelligence collab
mRNA specialist Moderna (Nasdaq: MRNA) has shared details of a
year-old collaboration with artificial intelligence leader
OpenAI.
The company behind the text and image generators ChatGPT and
Dall-E, OpenAI is a large language model expert which initiated
the most recent wave of AI enthusiasm when it released its tools
to the public in 2023.
Around that time, genetic medicine specialist Moderna started
working with the Californian firm to develop new…
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Try before you buy
• All the news that moves the needle in pharma and biotech.
• Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
• Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
• Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
• Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
• Daily roundup of key events in pharma and biotech.
• Monthly in-depth briefings on Boardroom appointments and M&A news.
• Choose from a cost-effective annual package or a flexible monthly subscription.
